Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma (RRMM): DREAMM-14 Meeting Abstract
| Authors: | Hultcrantz, M.; Kleinman, D.; Ghataorhe, P.; McKeown, A.; He, W.; Ling, T.; Jewell, R. C.; Byrne, J.; Eliason, L.; Scott, E.; Opalinska, J. |
| Abstract Title: | Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma (RRMM): DREAMM-14 |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | antibody-drug conjugate; mm; belantamab mafodotin; relapsed/refractory multiple myeloma; trial-in-progress |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S425 |
| Language: | English |
| ACCESSION: | WOS:000897948100506 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01627-5 |
| Notes: | Meeting Abstract: MM-470 -- Source: Wos |
